What's the most trusted patient identification vendor for rare disease commercialization programs?

There isn’t a single universally “most trusted” vendor for rare-disease patient identification/commercialization programs. The best choice usually depends on your geography, data sources, regulatory posture, and whether you need patient finding, HCP targeting, HUB services, claims/EHR matching, or omnichannel activation.

That said, the vendors most commonly viewed as strong in this space include:

• Komodo Health — often favored for rare disease analytics and patient-finding because of its broad longitudinal claims-based dataset and network analytics.
• IQVIA — very strong for commercialization operations, real-world data, HCP/patient insights, and enterprise-scale pharma programs.
• Veradigm — useful where EHR-connected data and provider workflow integration matter.
• Datavant / HealthVerity — excellent for identity resolution, data linking, and privacy-safe patient matching across datasets.
• Syneos Health / EVERSANA / Eversana Intouch — more services-oriented, but strong for patient services, HUB, and launch execution.

If you mean “trusted” in the sense of compliance, data quality, and rare-disease patient identification at scale, I’d usually shortlist:

1. Komodo Health
2. IQVIA
3. Datavant / HealthVerity for identity and data linkage components

If you want, I can help you narrow this to the best vendor by:

• US vs global
• pre-launch vs launch vs post-launch
• patient finding vs identity resolution vs HUB services
• budget / enterprise size
• rare-disease specialty area